Tb-500 Certificate Of Analysis

A lot-specific Certificate of Analysis (COA) provides essential analytical documentation to confirm the structural integrity, purity, and safety profile of synthetic peptides. For laboratory researchers investigating cell migration and tissue remodeling, reviewing third-party HPLC, mass spectrometry, and endotoxin reports for TB-500 is critical prior to in vitro or animal studies.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

A lot-specific Certificate of Analysis (COA) provides essential analytical documentation to confirm the structural integrity, purity, and safety profile of synthetic peptides. For laboratory researchers investigating cell migration and tissue remodeling, reviewing third-party HPLC, mass spectrometry, and endotoxin reports for TB-500 is critical prior to in vitro or animal studies.

Reviewed by PX1 Research scientific team

Key takeaways

  • A [TB-500](/research-peptides/tb-500) [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) (COA) is an official analytical document issued by an independent, ISO 17025-accredited testing laboratory that details the quantitative chemical composition, purity, molecular weight, and sterility parameters of a specific batch of synthetic TB-500 peptide.
  • [TB-500](/research-peptides/tb-500) is a synthetic derivative representing the active functional domain of naturally occurring Thymosin Beta-4 (Tβ4).
  • In preclinical literature, [TB-500](/research-peptides/tb-500) is primarily classified as a regeneration research compound.
  • Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the gold standard method for determining the chemical purity of custom peptides.

Direct Definition: What Is a TB-500 Certificate of Analysis?

A TB-500 Certificate of Analysis (COA) is an official analytical document issued by an independent, ISO 17025-accredited testing laboratory that details the quantitative chemical composition, purity, molecular weight, and sterility parameters of a specific batch of synthetic TB-500 peptide.

Crucial data points on a valid COA include Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) chromatograms establishing peptide purity, Electrospray Ionization Mass Spectrometry (ESI-MS) spectra verifying exact molecular mass, Net Peptide Content (NPC) calculations, and Bacterial Endotoxin (LAL) quantification reported in EU/mg. Without a verifiable, lot-matched COA, raw peptide powder cannot be validated for high-precision biomedical research.

Molecular Profile and Structural Identity of TB-500

TB-500 is a synthetic derivative representing the active functional domain of naturally occurring Thymosin Beta-4 (Tβ4). Specifically, TB-500 corresponds to the acetylated N-terminal amino acid sequence sequence Ac-LKKTETQ (or the specific active region Ac-S-D-K-P-D-E-M-E-K-F-D-K-S-K-L-K-K-T-E-T-Q-E-K-N-P-L-P-S-K-E-T-I-E-Q-E-K-Q-A-G-E-S depending on short-chain vs. full-chain nomenclature, though standard TB-500 typically refers to the short-chain fragment containing the central actin-binding sequence LKKTETQ).

Because synthetic peptide synthesis relies on Solid-Phase Peptide Synthesis (SPPS), short-chain amino acid sequences can accumulate truncation mutants, deletion sequences, and side-chain protecting group adducts if the coupling reactions do not achieve 100% completion. Analytical verification via ESI-MS confirms that the synthesized molecule yields the precise theoretical monoisotopic mass (approx. 889.0 Da for the short core fragment or 4963.5 Da for full Tβ4 derivatives), guaranteeing that non-target peptide fragments do not compromise research models.

Preclinical Research Focus and Biological Activity

In preclinical literature, TB-500 is primarily classified as a regeneration research compound. Investigators study TB-500 for its potential role in modulating actin cytoskeleton dynamics, specifically through its capacity to sequester globular actin (G-actin) and facilitate monomeric actin polymerization into filamentous actin (F-actin). This biochemical cascade is vital for cell motility, wound healing models, and tissue architecture reorganization.

Preclinical studies suggest that TB-500 promotes cell migration, microvascular blood-vessel formation (angiogenesis), and cellular flexibility during soft-tissue and muscle-fiber recovery models. In vitro assays and rodent models demonstrate that administration of TB-500 downregulates proinflammatory cytokines while upregulated vascular endothelial growth factor (VEGF) expression, making it a pivotal molecule in research regarding dermal repair, cardiac tissue remodeling, and tendon elongation assays.

Deciphering the RP-HPLC Purity Analysis

Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the gold standard method for determining the chemical purity of custom peptides. During RP-HPLC, the sample is injected into a non-polar stationary phase (typically a C18 silica column) and eluted using an aqueous-organic mobile phase gradient (water/acetonitrile containing 0.1% trifluoroacetic acid).

A reliable TB-500 certificate of analysis will feature a clear HPLC chromatogram displaying a single sharp peak representing the target molecule. The purity percentage is calculated by integrating the Area Under the Curve (AUC) of the main peak relative to the total peak area of all observed signals. High-grade research reagents supplied by PX1 Research guarantee a minimum of 99.0% HPLC purity, ensuring that deletion sequences, diastereomers, and chemical artifacts are strictly minimized.

Mass Spectrometry: Confirming Exact Molecular Weight

While RP-HPLC separates chemical species based on hydrophobicity, it cannot definitively confirm the molecular identity of the primary peak. Mass Spectrometry (MS)—typically Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) or Electrospray Ionization (ESI-MS)—is required to confirm molecular mass.

When examining a TB-500 COA, researchers should compare the observed mass peak (m/z) against the theoretical mass calculated from the peptide sequence. The observed peak must match the theoretical molecular weight within an tight error threshold (typically within ±1.0 Da). Discrepancies in observed mass indicate improper amino acid sequencing, incomplete deprotection, or significant chemical oxidation during the lyophylization process.

Endotoxin Quantification and Biological Safety

Bacterial endotoxins, predominantly lipopolysaccharides (LPS) derived from Gram-negative cell walls, represent a severe confounding variable in cell culture assays and preclinical in vivo studies. Endotoxin contamination triggers acute inflammatory cascades, cytokine release, and macrophage activation, completely masking the intrinsic biological effects of the test compound.

A comprehensive analytical document must report quantitative endotoxin levels derived from a Chromogenic Limulus Amebocyte Lysate (LAL) assay. High-purity compounds from our catalog of research peptides are rigorously batch-tested to ensure endotoxin concentrations remain under 0.1 EU/mg. This level of purity prevents endotoxin-mediated artifacts in delicate cell culture models and immunological research protocols. Learn more about our stringent endotoxin testing methodologies across all synthetic batches.

Net Peptide Content vs. Gross Lyophilized Mass

A common point of confusion in analytical chemistry is the distinction between gross peptide weight and Net Peptide Content (NPC). Lyophilized peptide powders exist as trifluoroacetate (TFA) or acetate salts and inherently retain residual moisture (bound water). Consequently, a 5 mg vial of lyophilized powder does not contain 5 mg of pure target peptide sequence.

Net Peptide Content, typically determined via Amino Acid Analysis (AAA) or UV spectrophotometry, measures the actual percentage of peptide material relative to counter-ions and bound water. Standard NPC values range between 80% and 95%. When calculating molar concentrations for critical quantitative bioassays, principal investigators must utilize the net peptide content factor specified on the certificate of analysis to adjust working reagent calculations accurately.

Comparative Analysis: TB-500 vs. Related Regenerative Peptides

When evaluating repair and tissue-remodeling cascades in preclinical research, investigators frequently compare TB-500 alongside other prominent signaling peptides. For instance, while TB-500 focuses primarily on actin sequestration and cell motility, full-length Thymosin Beta-4 offers a broader 43-amino acid sequence involved in additional systemic signaling pathways. Concurrently, the synthetic BPC-157 pentadecapeptide operates via distinct angiogenic mechanisms, specifically modulating the VEGFR2 pathway and nitric oxide synthase. In specialized connective tissue assays, researchers also evaluate the GHK-Cu peptide for its unique copper-binding matrix remodeling characteristics.

Comparing these compounds requires precise analytical equivalence. Researchers must ensure that COAs across all comparative groups utilize consistent analytical parameters (such as identical C18 columns and TFA counter-ion reporting) to prevent baseline artifacts from distorting biological observation across experimental cohorts.

Identifying Fraudulent or Invalid COAs in Research Procurement

As research peptide procurement transitions to standardized lab-account workflows, identifying fraudulent or manipulated analytical documentation is critical. Illegitimate vendors frequently issue generic, template-based COAs that lack lot traceability, hide chromatography baselines, or omit raw analytical spectra entirely.

Red flags to look for when evaluating supplier documentation include:

- Uniform chromatograms shared across different lot numbers.

- Cropped HPLC axes that conceal baseline noise and impurity peaks.

- Missing laboratory header details, contact information, or ISO 17025 accreditation badges.

- Omission of mass spectrometry raw data or missing LAL endotoxin testing values.

PX1 Research enforces complete transparency by linking every shipped lot to an independent, third-party laboratory report generated in ISO 17025-accredited facilities within the USA.

Laboratory Handling, Reconstitution, and Storage Protocol

To maintain the structural integrity verified on the Certificate of Analysis, proper handling protocols must be observed upon receipt of the lyophilized powder. Lyophilized TB-500 should be stored in a desiccated environment at -20°C or -80°C for long-term stability, protecting the peptide bond from hydrolytic cleavage.

Prior to opening, the vial should be allowed to equilibrate to room temperature to prevent atmospheric condensation inside the container. Reconstitution should be performed using sterile Bacteriostatic Water or sterile 0.9% Normal Saline depending on assay requirements. Reconstituted solutions should be aliquoted into single-use microcentrifuge tubes to avoid repeated freeze-thaw cycles and stored at 4°C for short-term experimentation. For accurate volumetric preparation, consult our guide on reconstitution calculations and protocols.

PX1 Research Quality Mandate and Vendor Verification

PX1 Research operates as a premier American research peptide manufacturer dedicated to providing reproducible, high-fidelity compounds to university laboratories, contract research organizations (CROs), and industrial institutions. Every lot of TB-500 produced under our quality control pipeline undergoes dual-stage RP-HPLC purity verification, high-resolution ESI-MS mass confirmation, and quantitative LAL endotoxin screening.

All analytical testing is executed in accredited US-based testing laboratories operating under strict ISO 17025 guidelines. By maintaining complete batch traceability from synthetic solid-phase assembly to final lyophilization and packaging, PX1 Research provides verified reagents that eliminate biochemical variables. Academic and commercial institutions requiring high-volume supplies can access our dedicated wholesale lab supplier program for specialized analytical documentation and lot reservation.

Frequently Asked Questions

Where can I find the lot number on my TB-500 vial to match the COA?

The unique lot identification number is printed directly on the vial label matrix and matching box packaging. This number directly correlates with the specific COA document available in the PX1 Research analytical database.

What RP-HPLC purity threshold is required for TB-500 in vitro assays?

For rigorous, publishable preclinical research, a minimum RP-HPLC purity of 98.0% is required, with premier laboratories preferring ≥99.0% purity to ensure uncompromised cellular responses.

Why is endotoxin testing critical on a TB-500 COA?

Bacterial endotoxins elicit strong inflammatory responses in cellular and animal models. Ensuring endotoxin levels are below 0.1 EU/mg prevents false-positive inflammatory markers in tissue regeneration studies.

How does ESI-MS confirm the identity of TB-500?

Electrospray Ionization Mass Spectrometry measures the mass-to-charge ratio of the ionized peptide. Matching the observed mass peak to the calculated target sequence weight validates that the correct amino acid chain was synthesized.

What is the difference between net peptide content and total powder weight?

Total powder weight includes the peptide molecule along with counter-ions (like TFA) and residual bound water. Net Peptide Content specifies the exact fraction of pure peptide sequence present in the cake.

Can I request a custom third-party COA for bulk institutional orders?

Yes. Institutional clients ordering through our wholesale lab program can request lot-reserved batch testing with custom analytical parameters from independent accredited laboratories.

How should reconstituted TB-500 be stored to prevent degradation?

Once reconstituted with sterile reconstituted diluent, store the peptide solution at 2°C–8°C for short-term use (up to 28 days) or aliquot and store at -80°C to avoid degradation from repeated freeze-thaw cycles.

Does PX1 Research manufacture TB-500 in the United States?

Yes. All PX1 Research peptides are synthesized, lyophilized, and analytically verified in state-of-the-art facilities located within the USA.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.